severe hip arthritis; given too much dosage of the Pfizer covid adult formulation bivalent vaccine; a Moderna booster dose was drawn up and given. Moderna booster dose was given instead of Pfizer dose booster.; Trochanteric bursitis; Facial rash; This is a spontaneous report received from a contactable reporter(s) (Nurse) from medical information team.  A 66-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 08Dec2022 at 17:10 as dose 3 (booster), single (Lot number: GH9693, Expiration Date: 13Dec2022) at the age of 66 years intramuscular for covid-19 immunisation. The patient didn't receive elasomeran (MODERNA COVID-19 VACCINE). The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: influenza, administration date: 10Nov2022, when the patient was 66-year-old, for Immunization; Covid-19 vaccine (DOSE 1, SINGLE, manufacturer unknown), for COVID-19 immunization; Covid-19 vaccine (DOSE 2, SINGLE, manufacturer unknown), for COVID-19 immunization.  The following information was reported: RASH (non-serious) with onset 08Dec2022, outcome "unknown", described as "Facial rash"; GREATER TROCHANTERIC PAIN SYNDROME (non-serious) with onset 08Dec2022, outcome "unknown", described as "Trochanteric bursitis"; WRONG PRODUCT ADMINISTERED (non-serious) with onset 08Dec2022 at 17:10, outcome "unknown", described as "a Moderna booster dose was drawn up and given. Moderna booster dose was given instead of Pfizer dose booster."; OVERDOSE (non-serious) with onset 08Dec2022 at 17:10, outcome "unknown", described as "given too much dosage of the Pfizer covid adult formulation bivalent vaccine"; ARTHRITIS (non-serious), outcome "unknown", described as "severe hip arthritis".  Additional information: The caller wanted to know if there was anything specific, they need to tell the patient. This report was non-serious.  The patient did not provide information regarding the reported adverse event(s) with the use of the product was reported.Prior vaccinations (within 4 weeks) Unknown. For Facial rash patient was given referral to dermatology due to squamous cell.C OVID booster was given at the end of visit. The patient did not have their COVID card but stated had received prior doses, and unsure of which vaccine previously taken. COVID vials were in a Ziplock bag in fridge labeled on the bag as Moderna, and a Moderna booster dose was drawn up & given. While charting the vaccine it was then noted that the vial was Pfizer bivalent and incorrect dosage was given. Moderna booster dose was given instead of Pfizer dose booster. the error was not noticed and intercepted before the product was supplied to the patient. It was reported as Inadvertent human error.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.   Follow-up (09Feb2023): This is a spontaneous follow-up report received from a contactable nurse. This nurse reported in response to HCP letter sent via follow-up letter which included that: Updated Information includes: Patient's Initials and DOB captured, Historical Vaccine Influenza and new dose 1,2 COVID-19 vaccine added, suspect dose number and dose description updated, vaccine facility information updated, "Moderna COVID-19 Vaccine" added as co-SD and product not administered ticked, new AEs "Wrong vaccine administered, "Trochanteric bursitis" onset date added and "Facial rash" and "severe hip arthritis" added. Concomitant Therapy captured as none